{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:41:17Z","timestamp":1792680077952,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>5-Fluorouracil (5-FU) resistance remains a significant challenge in the treatment of gastric cancer, limiting its clinical efficacy. Our study identifies NUSAP1, a nucleolar and spindle-associated protein, as a key driver of 5-FU resistance in gastric cancer. Proteomic analyses of 5-FU-resistant gastric cancer cell lines revealed that NUSAP1 is significantly upregulated, and functional studies demonstrated its essential role in promoting resistance, proliferation, migration, invasion, and tumor growth. Mechanistic investigations revealed that NUSAP1 undergoes asymmetric dimethylation (ADMA) at R418 and R422, mediated by PRMT1, with the R422 site being critical for its function. NUSAP1 interacts with the PEST domain of Notch2 through its R422 site, inhibiting Notch2 ubiquitination and stabilizing its expression, thereby activating the Notch2 signaling pathway. This pathway is closely linked to gastric cancer progression and chemoresistance. Inhibition of PRMT1 or mutation of the R422 site abrogated NUSAP1\u2019s ability to stabilize Notch2 and regulate downstream signaling. These findings unveil a novel mechanism by which NUSAP1 promotes 5-FU resistance in gastric cancer and highlight the therapeutic potential of targeting the NUSAP1-Notch2 axis or PRMT1 in overcoming chemoresistance.<\/jats:p>","DOI":"10.1038\/s41419-025-07723-9","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T08:53:47Z","timestamp":1747731227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["PRMT1-catalyzed NUSAP1 methylation enhances Notch2 signaling and 5-FU resistance in gastric cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Suting","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shitong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7276-1995","authenticated-orcid":false,"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"7723_CR1","doi-asserted-by":"publisher","unstructured":"Naro C, Ruta V, Sette C. Splicing dysregulation: hallmark and therapeutic opportunity in pancreatic cancer. Trends Mol Med. https:\/\/doi.org\/10.1016\/j.molmed.2024.11.007 2024.","DOI":"10.1016\/j.molmed.2024.11.007"},{"key":"7723_CR2","doi-asserted-by":"publisher","first-page":"6181","DOI":"10.7150\/ijbs.103187","volume":"20","author":"C Shan","year":"2024","unstructured":"Shan C, Wang Y, Wang Y. The crosstalk between autophagy and Nrf2 signaling in cancer: from biology to clinical applications. Int J Biol Sci. 2024;20:6181\u2013206.","journal-title":"Int J Biol Sci"},{"key":"7723_CR3","doi-asserted-by":"publisher","first-page":"107447","DOI":"10.1016\/j.pharmthera.2019.107447","volume":"206","author":"S Vodenkova","year":"2020","unstructured":"Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vymetalkova V. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. Pharmacol Ther. 2020;206:107447.","journal-title":"Pharmacol Ther"},{"key":"7723_CR4","doi-asserted-by":"publisher","first-page":"115137","DOI":"10.1016\/j.ejca.2024.115137","volume":"214","author":"JFM Geerts","year":"2024","unstructured":"Geerts JFM, Pape M, Vissers PAJ, Verhoeven RHA, Mostert B, Wijnhoven BPL, et al. Patient access to perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin and docetaxel in patients with resectable gastric cancer in the Netherlands. Eur J Cancer. 2024;214:115137.","journal-title":"Eur J Cancer"},{"key":"7723_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107534","volume":"210","author":"R Roskoski Jr","year":"2024","unstructured":"Roskoski R Jr. Targeted and cytotoxic inhibitors used in the treatment of breast cancer. Pharmacol Res. 2024;210:107534.","journal-title":"Pharmacol Res"},{"key":"7723_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111285","volume":"137","author":"C Sethy","year":"2021","unstructured":"Sethy C, Kundu CN. 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition. Biomed Pharmacother. 2021;137:111285.","journal-title":"Biomed Pharmacother"},{"key":"7723_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","volume":"379","author":"YJ Bang","year":"2012","unstructured":"Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379:315\u201321.","journal-title":"Lancet"},{"key":"7723_CR8","doi-asserted-by":"crossref","unstructured":"Das PK, Islam F, Lam AK. The roles of cancer stem cells and therapy resistance in colorectal carcinoma. Cells. 2020;9:1392.","DOI":"10.3390\/cells9061392"},{"key":"7723_CR9","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1158\/1078-0432.CCR-13-1854","volume":"20","author":"Y Touil","year":"2014","unstructured":"Touil Y, Igoudjil W, Corvaisier M, Dessein AF, Vandomme J, Monte D, et al. Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes\/YAP axis. Clin Cancer Res. 2014;20:837\u201346.","journal-title":"Clin Cancer Res"},{"key":"7723_CR10","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/mc.22526","volume":"56","author":"S Kulsum","year":"2017","unstructured":"Kulsum S, Sudheendra HV, Pandian R, Ravindra DR, Siddappa G, R N, et al. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition. Mol Carcinog. 2017;56:694\u2013711.","journal-title":"Mol Carcinog"},{"key":"7723_CR11","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1083\/jcb.200302129","volume":"162","author":"T Raemaekers","year":"2003","unstructured":"Raemaekers T, Ribbeck K, Beaudouin J, Annaert W, Van Camp M, Stockmans I, et al. NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization. J Cell Biol. 2003;162:1017\u201329.","journal-title":"J Cell Biol"},{"key":"7723_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.yexcr.2018.03.039","volume":"367","author":"G Han","year":"2018","unstructured":"Han G, Wei Z, Cui H, Zhang W, Wei X, Lu Z, et al. NUSAP1 gene silencing inhibits cell proliferation, migration and invasion through inhibiting DNMT1 gene expression in human colorectal cancer. Exp Cell Res. 2018;367:216\u201321.","journal-title":"Exp Cell Res"},{"key":"7723_CR13","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1080\/15384101.2022.2074199","volume":"21","author":"Y Hu","year":"2022","unstructured":"Hu Y, Xue Z, Qiu C, Feng Z, Qi Q, Wang J, et al. Knockdown of NUSAP1 inhibits cell proliferation and invasion through downregulation of TOP2A in human glioblastoma. Cell Cycle. 2022;21:1842\u201355.","journal-title":"Cell Cycle"},{"key":"7723_CR14","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1002\/jcp.29282","volume":"235","author":"Z Xu","year":"2020","unstructured":"Xu Z, Wang Y, Xiong J, Cui F, Wang L, Peng H. NUSAP1 knockdown inhibits cell growth and metastasis of non-small-cell lung cancer through regulating BTG2\/PI3K\/Akt signaling. J Cell Physiol. 2020;235:3886\u201393.","journal-title":"J Cell Physiol"},{"key":"7723_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41392-020-0137-7","volume":"5","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, He J, Li Y, Lv S, Cui H. NUSAP1 potentiates chemoresistance in glioblastoma through its SAP domain to stabilize ATR. Signal Transduct Target Ther. 2020;5:44.","journal-title":"Signal Transduct Target Ther"},{"key":"7723_CR16","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s00432-024-05927-8","volume":"150","author":"Y Ge","year":"2024","unstructured":"Ge Y, Wang B, Xiao J, Wu H, Shao Q. NUSAP1 promotes gastric cancer radioresistance by inhibiting ubiquitination of ANXA2 and is suppressed by miR-129-5p. J Cancer Res Clin Oncol. 2024;150:406.","journal-title":"J Cancer Res Clin Oncol"},{"key":"7723_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.591698","volume":"10","author":"H Guo","year":"2020","unstructured":"Guo H, Zou J, Zhou L, Zhong M, He Y, Huang S, et al. NUSAP1 promotes gastric cancer tumorigenesis and progression by stabilizing the YAP1 protein. Front Oncol. 2020;10:591698.","journal-title":"Front Oncol"},{"key":"7723_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103209","volume":"74","author":"X Gu","year":"2024","unstructured":"Gu X, Zhu Y, Su J, Wang S, Su X, Ding X, et al. Lactate-induced activation of tumor-associated fibroblasts and IL-8-mediated macrophage recruitment promote lung cancer progression. Redox Biol. 2024;74:103209.","journal-title":"Redox Biol"},{"key":"7723_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216285","volume":"567","author":"M Chen","year":"2023","unstructured":"Chen M, Cen K, Song Y, Zhang X, Liou YC, Liu P, et al. NUSAP1-LDHA-Glycolysis-Lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma. Cancer Lett. 2023;567:216285.","journal-title":"Cancer Lett"},{"key":"7723_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07290-5","volume":"15","author":"S Chen","year":"2024","unstructured":"Chen S, Zhang D, Du Y, Shi J, Gu S, Zhou X, et al. Targeting TRAF6\/IRF3 axis to inhibit NF-kappaB-p65 nuclear translocation enhances the chemosensitivity of 5-FU and reverses the proliferation of gastric cancer. Cell Death Dis. 2024;15:924.","journal-title":"Cell Death Dis"},{"key":"7723_CR21","doi-asserted-by":"crossref","unstructured":"Chiu CL, Li CG, Verschueren E, Wen RM, Zhang D, Gordon CA, et al. NUSAP1 binds ILF2 to modulate R-loop accumulation and DNA damage in prostate cancer. Int J Mol Sci. 2023;24:6258.","DOI":"10.3390\/ijms24076258"},{"key":"7723_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41388-021-02078-9","volume":"41","author":"F Wang","year":"2022","unstructured":"Wang F, Zhang J, Tang H, Pang Y, Ke X, Peng W, et al. Nup54-induced CARM1 nuclear importation promotes gastric cancer cell proliferation and tumorigenesis through transcriptional activation and methylation of Notch2. Oncogene. 2022;41:246\u201359.","journal-title":"Oncogene"},{"key":"7723_CR23","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.gendis.2023.02.006","volume":"10","author":"F Wang","year":"2023","unstructured":"Wang F, Chen S, Peng S, Zhou X, Tang H, Liang H, et al. PRMT1 promotes the proliferation and metastasis of gastric cancer cells by recruiting MLXIP for the transcriptional activation of the beta-catenin pathway. Genes Dis. 2023;10:2622\u201338.","journal-title":"Genes Dis"},{"key":"7723_CR24","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.molmed.2019.05.007","volume":"25","author":"J Jarrold","year":"2019","unstructured":"Jarrold J, Davies CC. PRMTs and arginine methylation: cancer\u2019s best-kept secret?. Trends Mol Med. 2019;25:993\u20131009.","journal-title":"Trends Mol Med"},{"key":"7723_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.molcel.2016.11.003","volume":"65","author":"RS Blanc","year":"2017","unstructured":"Blanc RS, Richard S. Arginine methylation: the coming of age. Mol Cell. 2017;65:8\u201324.","journal-title":"Mol Cell"},{"key":"7723_CR26","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1038\/s41418-020-00615-9","volume":"27","author":"Z Li","year":"2020","unstructured":"Li Z, Wang D, Lu J, Huang B, Wang Y, Dong M, et al. Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis. Cell Death Differ. 2020;27:3226\u201342.","journal-title":"Cell Death Differ"},{"key":"7723_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216647","volume":"585","author":"J Sun","year":"2024","unstructured":"Sun J, Dong M, Xiang X, Zhang S, Wen D. Notch signaling and targeted therapy in non-small cell lung cancer. Cancer Lett. 2024;585:216647.","journal-title":"Cancer Lett"},{"key":"7723_CR28","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.1158\/0008-5472.CAN-11-0036","volume":"71","author":"C Gungor","year":"2011","unstructured":"Gungor C, Zander H, Effenberger KE, Vashist YK, Kalinina T, Izbicki JR, et al. Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer. Cancer Res. 2011;71:5009\u201319.","journal-title":"Cancer Res"},{"key":"7723_CR29","doi-asserted-by":"crossref","unstructured":"Kerdkumthong K, Roytrakul S, Songsurin K, Pratummanee K, Runsaeng P, Obchoei S. Proteomics and bioinformatics identify drug-resistant-related genes with prognostic potential in cholangiocarcinoma. Biomolecules. 2024;14:969.","DOI":"10.3390\/biom14080969"},{"key":"7723_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102344","volume":"53","author":"W Liu","year":"2022","unstructured":"Liu W, Zhao Y, Wang G, Feng S, Ge X, Ye W, et al. TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS\/AMPK\/mTOR\/autophagy signaling. Redox Biol. 2022;53:102344.","journal-title":"Redox Biol"},{"key":"7723_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42420-1","volume":"14","author":"Z Lin","year":"2023","unstructured":"Lin Z, Yang P, Hu Y, Xu H, Duan J, He F, et al. RING finger protein 13 protects against nonalcoholic steatohepatitis by targeting STING-relayed signaling pathways. Nat Commun. 2023;14:6635.","journal-title":"Nat Commun"},{"key":"7723_CR32","doi-asserted-by":"publisher","first-page":"15931","DOI":"10.1021\/acs.jmedchem.4c00490","volume":"67","author":"T Hendrickson-Rebizant","year":"2024","unstructured":"Hendrickson-Rebizant T, Sudhakar SRN, Rowley MJ, Frankel A, Davie JR, Lakowski TM. Structure, function, and activity of small molecule and peptide inhibitors of protein arginine methyltransferase 1. J Med Chem. 2024;67:15931\u201346.","journal-title":"J Med Chem"},{"key":"7723_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.115060","volume":"384","author":"J Zaccarelli-Magalhaes","year":"2024","unstructured":"Zaccarelli-Magalhaes J, Citadin CT, Langman J, Smith DJ, Matuguma LH, Lin HW, et al. Protein arginine methyltransferases as regulators of cellular stress. Exp Neurol. 2024;384:115060.","journal-title":"Exp Neurol"},{"key":"7723_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.20517\/cdr.2018.01","volume":"1","author":"A Dominijanni","year":"2018","unstructured":"Dominijanni A, Gmeiner WH. Improved potency of F10 relative to 5-fluorouracil in colorectal cancer cells with p53 mutations. Cancer Drug Resist. 2018;1:48\u201358.","journal-title":"Cancer Drug Resist"},{"key":"7723_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115902","volume":"218","author":"J Hu","year":"2023","unstructured":"Hu J, Li A, Guo Y, Ma T, Feng S. The relationship between tumor metabolism and 5-fluorouracil resistance. Biochem Pharm. 2023;218:115902.","journal-title":"Biochem Pharm"},{"key":"7723_CR36","doi-asserted-by":"crossref","unstructured":"Zhou M, Huang Y, Xu P, Li S, Duan C, Lin X, et al. PRMT1 promotes the self-renewal of leukemia stem cells by regulating protein synthesis. Adv Sci. 2024;12:e2308586.","DOI":"10.1002\/advs.202308586"},{"key":"7723_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00871-5","volume":"13","author":"B Yao","year":"2021","unstructured":"Yao B, Gui T, Zeng X, Deng Y, Wang Z, Wang Y, et al. PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling. Genome Med. 2021;13:58.","journal-title":"Genome Med"},{"key":"7723_CR38","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1111\/febs.17037","volume":"291","author":"T Nakamura","year":"2024","unstructured":"Nakamura T, Sugeno N, Hasegawa T, Ikeda K, Yoshida S, Ishiyama S, et al. Alpha-synuclein promotes PRMT5-mediated H4R3me2s histone methylation by interacting with the BAF complex. FEBS J. 2024;291:1892\u2013908.","journal-title":"FEBS J"},{"key":"7723_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06149-5","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Liu H, Ye M, Jiang M, Chen X, Song G, et al. Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion. Cell Death Dis. 2023;14:624.","journal-title":"Cell Death Dis"},{"key":"7723_CR40","doi-asserted-by":"crossref","unstructured":"Yuk N, Jung HJ. Inhibition of PRMT1 suppresses the growth of U87MG-derived glioblastoma stem cells by blocking the STAT3 signaling pathway. Int J Mol Sci. 2024;25:2950.","DOI":"10.3390\/ijms25052950"},{"key":"7723_CR41","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1111\/cas.16139","volume":"115","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Chen Z, Zhou Q, Meng S, Shi J, Mui S, et al. SMYD4 monomethylates PRMT5 and forms a positive feedback loop to promote hepatocellular carcinoma progression. Cancer Sci. 2024;115:1587\u2013601.","journal-title":"Cancer Sci"},{"key":"7723_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101461","volume":"5","author":"B Ku","year":"2024","unstructured":"Ku B, Eisenbarth D, Baek S, Jeong TK, Kang JG, Hwang D, et al. PRMT1 promotes pancreatic cancer development and resistance to chemotherapy. Cell Rep. Med. 2024;5:101461.","journal-title":"Cell Rep. Med"},{"key":"7723_CR43","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s13046-024-03237-y","volume":"43","author":"Y Guo","year":"2024","unstructured":"Guo Y, Li Y, Zhou Z, Hou L, Liu W, Ren W, et al. Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancer. J Exp Clin Cancer Res. 2024;43:314.","journal-title":"J Exp Clin Cancer Res"},{"key":"7723_CR44","doi-asserted-by":"publisher","first-page":"F205","DOI":"10.1152\/ajprenal.90005.2013","volume":"306","author":"XM Wang","year":"2014","unstructured":"Wang XM, Yao M, Liu SX, Hao J, Liu QJ, Gao F. Interplay between the Notch and PI3K\/Akt pathways in high glucose-induced podocyte apoptosis. Am J Physiol Ren Physiol. 2014;306:F205\u201313.","journal-title":"Am J Physiol Ren Physiol"},{"key":"7723_CR45","doi-asserted-by":"publisher","first-page":"74","DOI":"10.31083\/j.fbl2902074","volume":"29","author":"W Xing","year":"2024","unstructured":"Xing W, Yang J, Zheng Y, Yao L, Peng X, Chen Y, et al. The role of the notch signaling pathway in the differentiation of human umbilical cord-derived mesenchymal stem cells. Front Biosci. 2024;29:74.","journal-title":"Front Biosci"},{"key":"7723_CR46","doi-asserted-by":"crossref","unstructured":"Parambath S, Selvraj NR, Venugopal P, Aradhya R. Notch signaling: an emerging paradigm in the pathogenesis of reproductive disorders and diverse pathological conditions. Int J Mol Sci. 2024;25:5423.","DOI":"10.3390\/ijms25105423"},{"key":"7723_CR47","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","volume":"7","author":"B Zhou","year":"2022","unstructured":"Zhou B, Lin W, Long Y, Yang Y, Zhang H, Wu K, et al. Notch signaling pathway: architecture, disease, and therapeutics. Signal Transduct Target Ther. 2022;7:95.","journal-title":"Signal Transduct Target Ther"},{"key":"7723_CR48","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s12672-024-01572-2","volume":"15","author":"Y Jin","year":"2024","unstructured":"Jin Y, Liu Q, Sun B, Li X, Wu J, Lin Z, et al. Pralatrexate represses the resistance of HCC cells to molecular targeted agents via the miRNA-34a\/Notch pathway. Discov Oncol. 2024;15:709.","journal-title":"Discov Oncol"},{"key":"7723_CR49","first-page":"837","volume":"9","author":"MX Xiu","year":"2019","unstructured":"Xiu MX, Liu YM. The role of oncogenic Notch2 signaling in cancer: a novel therapeutic target. Am J Cancer Res. 2019;9:837\u201354.","journal-title":"Am J Cancer Res"},{"key":"7723_CR50","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/hpb.12442","volume":"17","author":"S Kunnimalaiyaan","year":"2015","unstructured":"Kunnimalaiyaan S, Gamblin TC, Kunnimalaiyaan M. Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression. HPB. 2015;17:770\u20136.","journal-title":"HPB"},{"key":"7723_CR51","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.semcdb.2010.03.003","volume":"21","author":"H Takeuchi","year":"2010","unstructured":"Takeuchi H, Haltiwanger RS. Role of glycosylation of Notch in development. Semin Cell Dev Biol. 2010;21:638\u201345.","journal-title":"Semin Cell Dev Biol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07723-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07723-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07723-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T09:49:39Z","timestamp":1747734579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07723-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7723"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07723-9","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"5 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal studies complied with relevant ethical regulations for animal testing and research, and all procedures were approved by the Institutional Animal Care and Use Committee of Three Gorges Medical College.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"404"}}